San Antonio · Seed–Series A · 5 people tracked
Investment thesis
Targeted Technology Funds invests in early-stage life science and healthcare companies whose technologies can advance the practice of medicine and improve patient outcomes, as well as those that enhance the efficiency, cost, or functionality of developing and manufacturing life science products. The firm favors innovations with shorter time and lower cost to market that address compelling market needs offering the opportunity for enhanced returns. Investments span a broad range of healthcare categories, with particular emphasis on medical devices, life science tools, biotechnology, diagnostics, and specialty pharmaceuticals. The firm views its model as well suited to a healthcare environment that rewards better clinical outcomes and reduced costs.
Source: firm website, verified Aug 3, 2026.
Team · 5 people
from public directories
What they invest in
from 9 of 24 portfolio companiesHealthtech ×6Medical Devices ×5Biotech ×4Longevity ×1Robotics ×1Sports Tech ×1
HQs:United States×8United Kingdom×1
Investments · 24 tracked
founders shown can be your intro pathBy year:2018 · 12015 · 22014 · 12012 · 15 dated
Smith+Nephew is a medical technology company that develops products for the repair, regeneration, and replacement of soft and hard tissue, including sports medicine solutions for treating sporting injuries.
HealthtechMedical DevicesSports TechLondon, GB
Thomas James Smith(Founder)Horatio Nelson Smith(Co-founder)Deepak Nathin
PartnerAlan Dean· solo GP
Co-investorsAccess Venture PartnersAlphaDrive
Maker of the Spline-Fix External Fixator System for treating a range of bone fractures.
PartnerAlan Dean· solo GP
Aerin Medical develops non-invasive radiofrequency treatment systems for chronic nasal conditions, offering the VivAer stylus for nasal airway obstruction and RhinAer stylus for chronic rhinitis.
HealthtechMedical DevicesMountain View, US
Matt Brokaw(CEO & President)Derrick Sung(Executive Officer)Matthew Salkeld(Executive Officer)Irina Ridley(Executive Officer)Andre Cheng(Executive Officer)Fred Dinger(Executive Officer, Director)
PartnerAlan Dean· solo GP
Co-investorsLaunchCapitalOrbiMedQuesta CapitalAlly Bridge GroupHorizon
Medical device maker developing the Angel Catheter to prevent pulmonary embolism in critically ill patients; acquired by Mermaid Medical Group in 2018.
PartnerAlan Dean· solo GP
PartnerAlan Dean· solo GP
Provides technologies for detection, neutralization, and removal of endotoxin for bioresearch and bioprocess markets.
PartnerAlan Dean· solo GP
Developing the Surfacer Inside-Out Access Catheter System, a novel approach to central venous access.
San Antonio, US
Robert Coleman(Director)James Traa(Director)James Clifton(Executive Officer)
BoardAlan Dean(Director)
PartnerAlan Dean· solo GP
Bluegrass Vascular develops the Surfacer Inside-Out Access Catheter System, a medical device using an "Inside-Out" approach to restore and preserve central venous access in patients with chronically occluded veins such as the superior vena cava.
HealthtechMedical Devices
BoardJohn Gurley(Developer of the Inside-Out approach; Department of Cardiology, University of Kentucky)
PartnerAlan Dean· solo GP
Medical technology company focused on tissue regeneration and repair using proprietary scaffold materials.
PartnerAlan Dean· solo GP
Provides high-throughput, high-accuracy automated cellular patch clamp testing instruments for drug development research.
PartnerAlan Dean· solo GP
BiotechSan Antonio, US
James R. Garvin(Chief Executive Officer, President, Secretary and Treasurer)
PartnerAlan Dean· solo GP
BiotechHouston, US
Frank Tufaro(Executive Officer, Director)Brian Mooney(Executive Officer)Isaac Cheng(Director)Reenie McCarthy(Director)
BoardDaniel Watkins(Director)Drew Pardoll(Director)
PartnerAlan Dean· solo GP
Co-investorsTexas Ventures
Designs and manufactures instruments and devices for sinus surgery; acquired by Smith & Nephew in 2013.
PartnerAlan Dean· solo GP
HealthtechSan Antonio, US
Dennis F. Filips(Executive Officer, Director)David Schneider(Executive Officer, Director)Maggie Pemberton(Executive Officer)Ian Atkinson(Executive Officer, Director)Philip W. Faris(Executive Officer, Director)
BoardPaul Castella(Executive Officer, Director)in
PartnerAlan Dean· solo GP
Medical device company providing the neoClose Trocar Port Closure System for laparoscopic and minimally invasive surgery.
PartnerAlan Dean· solo GP
Oxnard, US
Vito SAN FILIPPO(Executive Officer)MARIANNE THERESA CRONIN(Executive Officer, Director)
PartnerAlan Dean· solo GP
Enhances drug discovery by optimizing protein solubility and stability; acquired by InventaBioTech in 2016.
PartnerAlan Dean· solo GP
PartnerAlan Dean· solo GP
StemBioSys develops cell culture technology, including the patented CELLvo Matrix that replicates the body's physiological microenvironment to expand mesenchymal stem cells and specialty cells while preserving their stem-like properties.
BiotechHealthtechLongevityMedical DevicesSan Antonio, US
Chen Xiao-Dong(Director)Steven Davis(Co-founder)Xiao-Dong Chen(Co-founder)Travis Block(Chief Technology Officer)Jean Cheever(Director)Mark D Horsey(Executive Officer)
PartnerAlan Dean· solo GP
Developer of an intraosseous medicine technology platform; acquired by Teleflex in 2013.
PartnerAlan Dean· solo GP
Co-investorsTullis Health Investors
Mid-stage drug developer of botanical anti-viral topical prescription candidates for skin diseases; acquired by TFS Corporation in 2017.
BiotechSan Antonio, US
BoardAlan Dean(Director)Ian William David Clements(Executive Officer, Director)Paul Castella(Director)Gary Frashier(Director)
PartnerAlan Dean· solo GP
Xenex builds pulsed Xenon UV light disinfection robots that deactivate pathogens missed during manual cleaning, used by hospitals to reduce environmental contamination and healthcare-associated infections.
HealthtechMedical DevicesRobotics
Mark (Tuck) Stibich(Co-founder)Julie Stachowiak(Co-founder)Morris Miller(Co-founder & CEO)inMark "Tuck" Stibich(Founder & Chief Scientific Officer)
PartnerAlan Dean· solo GP
Co-investorsBattery VenturesTectonic Ventures
World leader in UV room disinfection robot systems for healthcare facilities.
PartnerAlan Dean· solo GP
Exits · 7
IPOs and acquisitions across the tracked portfolioSmith+NephewNYSE: SNNBiO2 Medical, Inc.acq. by Mermaid Medical GroupENTrigue Surgical, Inc.acq. by Smith+NephewSantalis Pharmaceuticals, Inc.acq. by TFSSoluble Bioscience, LLCacq. by InventaBioTechVidacareacq. by TeleflexViroXis Corporation, Inc.acq. by TFS
Frequently asked questions
- How many investments has Targeted Technology Funds made?
- Targeted Technology Funds has 24 tracked investments, 6 of which have exited via acquisition or IPO.
- What stage does Targeted Technology Funds invest at?
- Targeted Technology Funds invests at the Seed, Series A stages.
- What sectors does Targeted Technology Funds focus on?
- Targeted Technology Funds focuses on Biotech, Deep Tech, Digital Health, Healthtech, Medical Devices.
- Where is Targeted Technology Funds located?
- Targeted Technology Funds is headquartered in San Antonio, US.
- Who does Targeted Technology Funds co-invest with?
- Targeted Technology Funds most often shares deals with Battery Ventures, LaunchCapital, OrbiMed, among 9 tracked co-investors.
Similar investors
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.
GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.